Prevention of Hernia After Loop Ileostomy Reversal
PHaLIR
1 other identifier
interventional
208
1 country
4
Brief Summary
PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery are randomized between retro muscular mesh Ultrapro Advanced or standard treatment without mesh.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Mar 2018
Longer than P75 for phase_2
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 24, 2018
CompletedFirst Posted
Study publicly available on registry
October 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
August 19, 2025
August 1, 2025
8.8 years
October 24, 2018
August 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Hernia
Hernia at the site of the stomal closure
One year
Secondary Outcomes (5)
Operation time
Three hours
Time for closing the stoma site
One hour
Hospital stay
Seven days
Postoperative pain
Thirty days
Postoperative complications
Thirty days
Study Arms (2)
Mesh reinforcement
EXPERIMENTALRetro muscular mesh at the stoma site.
No reinforcement
PLACEBO COMPARATORStandard closure of the abdominal wall
Interventions
Reinforcement of the abdominal wall with Ultrapro Advanced.
Eligibility Criteria
You may qualify if:
- Patients operated for low anterior resection for rectal cancer with a diverting loop ileostomy and planned for stoma reversal
You may not qualify if:
- Language barrier or cognitive disability
- Recurrent cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Stockholm South General Hospitalcollaborator
Study Sites (4)
Södertälje Hospital
Södertälje, Sweden
Stockholm South General Hospital
Stockholm, 11883, Sweden
Ersta Hospital
Stockholm, Sweden
Västmanland Hospital
Västerås, Sweden
Related Publications (1)
Eklov K, Bringman S, Lofgren J, Nygren J, Everhov AH. PHaLIR: prevent hernia after loop ileostomy reversal-a study protocol for a randomized controlled multicenter study. Trials. 2023 Sep 8;24(1):575. doi: 10.1186/s13063-023-07430-w.
PMID: 37684648DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Åsa Hallqvist Everhov, MS, PhD
Stockholm South General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The patient and the surgeon performing the follow-up are masked for the allocation
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
October 24, 2018
First Posted
October 25, 2018
Study Start
March 1, 2018
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2029
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share